Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and glutamine

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with glutamine in 1 studies

Compound Research Comparison

Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Recent Studies (post-2010)
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Studies
(glutamine)		Trials
(glutamine)		Recent Studies (post-2010) (glutamine)
6383124319,0627875,408

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aime, S; Barge, A; Cabella, C; Cravotto, G; Geninatti Crich, S; Stefania, R; Szabo, I; Tei, L1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and glutamine

ArticleYear
Tuning glutamine binding modes in Gd-DOTA-based probes for an improved MRI visualization of tumor cells.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2009, Volume: 15, Issue:1

    Topics: Animals; Contrast Media; Cyclization; Glutamine; Hepatocytes; Heterocyclic Compounds; Magnetic Resonance Imaging; Neoplasms; Organometallic Compounds; Rats; Tumor Cells, Cultured

2009